About Bolt Biotherapeutics

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.

Repeat Founder
Company Highlights
Year Founded

2015

icon-altEmployees

94

Location (HQ)

USA

Since Last Funding

3 years 3 months

Monthly Website Visitors

2.3K

icon-altTotal Investment Amt

$200M

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

-7.84%

icon-altYoY Headcount Growth

-12.14%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Medical

Biotechnology

Biotechnology Research

Pharmaceutical